Evidence Supporting the Superiority of Intraperitoneal Cisplatin Compared to Intraperitoneal Carboplatin for Salvage Therapy of Small-Volume Residual Ovarian Cancer

Authors:
  • BRBonnie Reichman
    Bonnie Reichman
  • THTom Hakes
    Tom Hakes
  • SRStephen Rubin
    Stephen Rubin
  • JLJohn L. Lewis
    John L. Lewis
  • WJWalter Jones
    Walter Jones
  • RBRichard Barakat
    Richard Barakat
  • JCJohn Curtin
    John Curtin
  • LALois Almadrones
    Lois Almadrones
  • WHWilliam Hoskins
    William Hoskins

Abstract
No abstract available